The Lancet Summit: Inflammation and Immunity in Disorders of the Brain and Mind
November 15-17, 2018 | NH Collection Barcelona Tower, Hospitalet de Llobregat, Barcelona, Spain
Join The Lancet Neurology and The Lancet Psychiatry for a landmark conference in the exciting clinical field of immunological disorders of the brain and mind. This developing area not only presents neurologists and psychiatrists with potential new treatments for their patients, but also demands a rethink of the boundaries of the two disciplines, and how they will move forward together. By bringing together both professions, this conference will provide vital education as well as launching future research and clinical collaborations.
The programme will cover recent, ongoing, and future research in the developing field of neuroimmunological disease including recent research findings regarding mechanisms of disease, and the translation of this knowledge into treatment, diagnosis, and the prevention of neurological and psychiatric disorders.
The event will have a translational focus, starting with the basic science of immunology and the brain, and then moving into the roles these systems play in neuropsychiatric health and disease, and ending with a clinically-focused debate on screening and treatment.
We welcome poster presentations.
Topics include:
• Autoimmunity in the central nervous system
• The blood-brain barrier in neurological and psychiatric illness
• The immune system and disorders of the brain and mind
• Screening for and managing neuroimmunological disorders in clinical practice
Abstract Submission Deadline: May 18, 2018
-
Sergio Baranzini, University of California San Francisco, USA
Premysl Bercik, McMaster University, Canada
Amit Bar-Or, University of Pennsylvania, USA
Lisa Boulanger, Princeton University, USA
Josep Dalmau, University of Barcelona, IDIBAPS, and ICREA, Spain and University of Pennsylvania, USA
Richard Daneman, University of California San Diego, USA
Betty Diamond, The Feinstein Institute for Medical Research, USA
Wayne Drevets, Johnson & Johnson, Inc, USA
Nicolas Glaichenhaus, CNRS/University Nice Sophia Antipolis, France
Michael Heneka, University of Bonn, Germany
Reinhard Hohlfeld, Ludwig Maximilians University of Munich, Germany
Golam M Khandaker, University of Cambridge, UK
Marion Leboyer, University Paris-Est Créteil, France
Belinda Lennox, Oxford University, UK
Emmanuel Mignot, Stanford University, USA
V. Hugh Perry, University of Southampton, UK
Tom Pollak, Kings College London, UK
Marco Prinz, University of Freiburg, Germany
Joan Santamaria, University of Barcelona, Spain
Akira Sawa, Johns Hopkins University Hospital, USA
Michal Schwartz, Weizmann Institute of Science, Israel
Iris Sommer, University Medical Center Groningen, The Netherlands
Hartmut Wekerle, Max Plank Institute of Neurobiology, Germany
Shen-Ying Zang, Rockefeller University, USA
- Elena Becker-Barroso, Editor, The Lancet Neurology, UK
- Niall Boyce, Editor, The Lancet Psychiatry, UK
- Josep Dalmau, University of Barcelona, IDIBAPS, and ICREA, Spain and University of Pennsylvania, USA
- Francesc Graus, University of Barcelona, Spain
- Marion Leboyer, University Paris-Est Créteil, France
- Akira Sawa, Johns Hopkins University Hospital, USA
